Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adjuvant medical treatment].

R Plagne1, P Chollet, M Legros

  • 1Service d'oncologie médicale, centre Jean-Perrin, Clermont-Ferrand.

La Revue Du Praticien
|April 1, 1990
PubMed
Summary

Adjuvant medical treatments like chemotherapy and endocrine therapy significantly reduce breast cancer recurrence and improve survival, especially in early stages. Precise analysis of prognostic factors, including tumor cells, helps determine optimal treatment indications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Value of a log book for patients receiving intravitreal injections].

Journal francais d'ophtalmologie·2023
Same author

[68/f-Progressive dyspnea on exertion and petechiae : Preparation for the medical specialist examination: part 43].

Der Internist·2021
Same author

[Multiple myeloma in an elderly patient with history of breast cancer : the value of multidisciplinary oncogeriatric collaboration].

Revue medicale de Liege·2021
Same author

[Comprehensive geriatric assessment (CGA) in elderly with cancer: For whom?].

La Revue de medecine interne·2016
Same author

Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer.

International journal of cancer·2015
Same author

Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Area of Science:

  • Oncology
  • Medical treatment efficacy

Context:

  • Adjuvant therapies are standard for most breast cancer patients.
  • These treatments aim to prevent cancer recurrence and improve survival rates.

Purpose:

  • To highlight the benefits of adjuvant chemotherapy and endocrine therapy.
  • To emphasize the role of prognostic factors in treatment decisions.

Summary:

  • Adjuvant medical treatments, including chemotherapy and endocrine therapy, are widely used in breast cancer management.
  • These therapies effectively delay and reduce cancer recurrences, leading to improved survival, particularly in early-stage disease.
  • They also enhance local treatment effectiveness, increasing the potential for breast conservation.

Impact:

Related Experiment Videos

  • Improved patient outcomes through reduced recurrence and enhanced survival.
  • Optimized treatment strategies based on detailed prognostic factor analysis.
  • Increased feasibility of breast-conserving surgery.